Bio-Path Holdings has raised USD 4 million in private funding. The transaction involved the issuance and sale of ~1.8 million common shares and an equivalent number of series A and B warrants at the price of USD 2.21 per share. The exclusive agent for the placement was H.C. Wainwright & Co.
The company intends to employ the proceeds from the funding primarily for working capital and other corporate purposes.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.